乳酸和乳酸化修饰在动脉粥样硬化性心血管疾病病理生理中的新作用。

IF 3.1 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Xianqiong Lu, Qiyuan Luo, Danfeng Yu, Yan He, Jiyu Chen
{"title":"乳酸和乳酸化修饰在动脉粥样硬化性心血管疾病病理生理中的新作用。","authors":"Xianqiong Lu, Qiyuan Luo, Danfeng Yu, Yan He, Jiyu Chen","doi":"10.1007/s10557-025-07732-y","DOIUrl":null,"url":null,"abstract":"<p><p>Atherosclerosis is a chronic disease that is characterized by lipid accumulation and inflammation in the arterial wall. Atherosclerotic plaques form beneath the intima of large and medium-sized arteries and this is a leading cause of ischemic heart disease and stroke. Recently, with the intensification of global aging trends, the prevalence of atherosclerosis has increased significantly. Lactate, which is a byproduct of glycolysis, plays crucial roles in cell signaling, inflammatory responses, and metabolic regulation. Research on lactate and lactylation modifications in atherosclerotic cardiovascular diseases has gradually gained attention. This article reviews the latest research progress on lactate and its modifications in atherosclerotic cardiovascular diseases; explores mechanisms in pathological processes such as inflammation, oxidative stress, and apoptosis; and analyzes the potential as biomarkers and therapeutic targets. This review provides a reference for further studies on the role of lactate and lactylation in atherosclerotic cardiovascular diseases.</p>","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Emerging Role of Lactate and Lactylation Modifications in the Pathophysiology of Atherosclerotic Cardiovascular Diseases.\",\"authors\":\"Xianqiong Lu, Qiyuan Luo, Danfeng Yu, Yan He, Jiyu Chen\",\"doi\":\"10.1007/s10557-025-07732-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Atherosclerosis is a chronic disease that is characterized by lipid accumulation and inflammation in the arterial wall. Atherosclerotic plaques form beneath the intima of large and medium-sized arteries and this is a leading cause of ischemic heart disease and stroke. Recently, with the intensification of global aging trends, the prevalence of atherosclerosis has increased significantly. Lactate, which is a byproduct of glycolysis, plays crucial roles in cell signaling, inflammatory responses, and metabolic regulation. Research on lactate and lactylation modifications in atherosclerotic cardiovascular diseases has gradually gained attention. This article reviews the latest research progress on lactate and its modifications in atherosclerotic cardiovascular diseases; explores mechanisms in pathological processes such as inflammation, oxidative stress, and apoptosis; and analyzes the potential as biomarkers and therapeutic targets. This review provides a reference for further studies on the role of lactate and lactylation in atherosclerotic cardiovascular diseases.</p>\",\"PeriodicalId\":9557,\"journal\":{\"name\":\"Cardiovascular Drugs and Therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Drugs and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10557-025-07732-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Drugs and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10557-025-07732-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

动脉粥样硬化是一种以动脉壁脂质积累和炎症为特征的慢性疾病。动脉粥样硬化斑块在大、中动脉内膜下形成,是缺血性心脏病和中风的主要原因。近年来,随着全球老龄化趋势的加剧,动脉粥样硬化的患病率明显增加。乳酸是糖酵解的副产物,在细胞信号传导、炎症反应和代谢调节中起着至关重要的作用。动脉粥样硬化性心血管疾病中乳酸和乳酸化修饰的研究逐渐受到重视。本文综述了乳酸及其在动脉粥样硬化性心血管疾病中的修饰作用的最新研究进展;探讨炎症、氧化应激和细胞凋亡等病理过程的机制;并分析了其作为生物标志物和治疗靶点的潜力。本文综述为进一步研究乳酸和乳酸化在动脉粥样硬化性心血管疾病中的作用提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Emerging Role of Lactate and Lactylation Modifications in the Pathophysiology of Atherosclerotic Cardiovascular Diseases.

Atherosclerosis is a chronic disease that is characterized by lipid accumulation and inflammation in the arterial wall. Atherosclerotic plaques form beneath the intima of large and medium-sized arteries and this is a leading cause of ischemic heart disease and stroke. Recently, with the intensification of global aging trends, the prevalence of atherosclerosis has increased significantly. Lactate, which is a byproduct of glycolysis, plays crucial roles in cell signaling, inflammatory responses, and metabolic regulation. Research on lactate and lactylation modifications in atherosclerotic cardiovascular diseases has gradually gained attention. This article reviews the latest research progress on lactate and its modifications in atherosclerotic cardiovascular diseases; explores mechanisms in pathological processes such as inflammation, oxidative stress, and apoptosis; and analyzes the potential as biomarkers and therapeutic targets. This review provides a reference for further studies on the role of lactate and lactylation in atherosclerotic cardiovascular diseases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardiovascular Drugs and Therapy
Cardiovascular Drugs and Therapy 医学-心血管系统
CiteScore
8.30
自引率
0.00%
发文量
110
审稿时长
4.5 months
期刊介绍: Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients. Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信